[autotag]Bruno Arruda da Silva[/autotag]’s UFC debut will have to wait.
Arruda da Silva (18-6 MMA, 0-0 UFC) was given a two-year suspension by the U.S. Anti-Doping Ageneny on Monday after testing positive for boldenone in an out-of-competition test collected on May 27, 2019.
Arruda da Silva was supposed to make his UFC debut on June 2019 in a middleweight bout against Deron Winn at UFC on ESPN+ 12. However, Arruda da Silva was pulled from the fight at the time for undisclosed reasons.
[lawrence-related id=528950,528127]
Arruda da Silva was unable to reduce the suspension after taking his case to an independent arbitrator on May 27. The Brazilian was unable to provide a plausible explanation for the failed drug test and did not declare a prior use of Boldenone on his on-boarding declaration upon joining the UFC.
The 30-year-old Arruda da Silva’s two-year period of ineligibility began on June 14, 2019, and thus he’ll be eligible for reinstatement on June 14, 2021.
Boldenone is a non-specified substance in the class of anabolic agents and is prohibited at all times under the UFC anti-doping policy UFC prohibited list.
[vertical-gallery id=528526]